Skip to main content
. 2010 Apr 27;10:23. doi: 10.1186/1471-2466-10-23

Figure 3.

Figure 3

Changes of exhaled breath condensate (EBC) 8-isoprostane (8-IP) concentrations between visit 1 -- first assessment (V1) and visit 2 -- follow up (V2) in treated patients and those who experienced spontaneous complete remission.